Future Neurology

Gene therapy for Parkinson''s disease: current approaches and future directions
pp. 583-585(3)
Authors: Schwartz, Guy; Feigin, Andrew

Prion protein in Alzheimer''s disease
pp. 587-590(4)
Authors: Watt, Nicole T; Hooper, Nigel M

Wrestling with epilepsy; potential roles for kainate receptor SUMOylation in regulating neuronal excitability
pp. 591-595(5)
Authors: Kaminski, Rafal M; Henley, Jeremy M

Cholesterol identified as a link between early and late-onset Alzheimer''s disease
pp. 597-599(3)

Selegiline transdermal system in the treatment of depressive disorders
pp. 601-611(11)
Authors: Baghai, Thomas C; Eser, Daniela; Schule, Cornelius; Born, Christoph; Rupprecht, Rainer

Methylphenidate transdermal system for the treatment of attention-deficit/hyperactivity disorder
pp. 613-620(8)
Author: Rugino, Thomas

Patient-controlled transdermal iontophoretic fentanyl system as an alternative to intravenous morphine PCA
pp. 621-627(7)
Author: Hartrick, Craig T

Identification of disease-related biomarkers by proteome analysis of cerebrospinal fluid in Guillain--Barréé syndrome
pp. 629-631(3)
Authors: Brettschneider, Johannes; Lehmensiek, Vera; Tumani, Hayrettin

Deep-brain stimulation
pp. 633-646(14)
Authors: Kringelbach, Morten L; Owen, Sarah LF; Aziz, Tipu Z

Radiation effects on neurogenic regions in the mammalian forebrain
pp. 647-659(13)
Authors: Andres-Mach, Marta; Rosi, Susanna; Rola, Radoslaw; Gupta, Nalin; Fike, John R

Neuropathic pain: multiple mechanisms at multiple sites
pp. 661-671(11)
Authors: Bee, Lucy A; Dickenson, Anthony H

Intravenous paracetamol: a review of efficacy and safety in therapeutic use
pp. 673-688(16)
Authors: Malaise, Olivier; Bruyere, Olivier; Reginster, Jean-Yves

Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS
pp. 689-697(9)
Author: Armstrong, Regina C